Neurohormonal and cytokine fluctuations following transcatheter closure for an atrial septal defect

Cytokine

Volumn 57, Issue 1, 2012, Pages 130-135

  Chamakou, Aikaterini C ^a   Dede, Eleni ^a   Moutafi, Antonia ^a   Thanopoulos, Vassileios ^b   Chryssanthopoulos, Stavros ^a   Loukopoulou, Sophia ^b   Pitsavos, Christos ^c   Stefanadis, Christodoulos ^c   Davos, Constantinos H ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amplatzer; Atrial septal defect; Inflammation

Indexed keywords

AMINO TERMINAL PRO ATRIAL NATRIURETIC PEPTIDE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 10; INTERLEUKIN 6; NATRIURETIC FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART LEFT ATRIUM VOLUME; HEART SURGERY; HEART VOLUME; HUMAN; LUNG BLOOD FLOW; MALE; MEDICAL ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; CYTOKINES; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEMODYNAMICS; HUMANS; MALE; NATRIURETIC PEPTIDES; NEUROTRANSMITTER AGENTS; ORGAN SIZE; YOUNG ADULT;

EID: 84155172046     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.10.002     Document Type: Article

References (31)

1. Petersen J., Felker M. Inflammatory biomarkers in heart failure. Le jacq 2006.
2. Giannakoulas G., Dimopoulos K., Bolger A., Tay E., Inuzuka R., Bedard E., et al. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol 2010, 869-873.
3. Bolger A., Sharma R., Li W., Leenarts M., Kalra P., Kemp M., et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002, 106:92-99.
4. Bolger A., Coats A., Gatzoulis M. Congenital heart disease: the original heart failure syndrome. Eur Heart J 2003, 24:970-976.
5. Adamopoulos S., Parissis J., Kremastinos D. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 2001, 3:517-526.
6. Iivainen T., Groundstroem K., Lahtela J.T., Talvensaari T.J., Pastemack A., Uusitalo A. Serum N-terminal atrial natriuretic peptide in adult patients late after surgical repair of atrial septal defect. Eur J Heart Fail 2000, 2:161-165.
7. Webb G., Gatzoulis M. Atrial septal defects in the adult. Circulation 2006, 114:1645-1653.
8. Amin Z., Hijazi Z.M., Bass J.L., Cheatham J.P., Hellenbrand W.E., Kleinman C.S. Erosion of amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommentations to minimize future risk. Catheter Cardiovasc Interv 2004, 63:496-502.
9. Dardas P., Ninios V., Mezilis N.E., Tsikaderis D.D., Thanopoulos V. Percutaneous closure of atrial septal defects: immediate and mid-term results. Hellenic J Cardiol 2010, 51:104-112.
10. Masure J., Gavora P., Formanek A., Hijazi Z.M. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Catheter Cardiovasc Diagn 1997, 42:388-393.
11. El-Menyar A. Cytokines and myocardial dysfunction: state of the art. J Cardiac Fail 2008, 14:89-98.
12. Sharma R., Bolger A., Li W., Davlouros P., Volk H.-D., Poole-Wilson P., et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol 2003, 92:188-193.
13. Takaya J., Ikemoto Y., Teragushi M., Nogi S., Kobayashi Y. Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatr Cardiol 2000, 21:378-381.
14. Hudzik B., Szkodzinski J., Romanowski W., Danikiewicz A., Wilczek K., Lekston A., et al. Serum interleukin-6 concetration reflects the extend of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery disease. Cytokine 2011.
15. Cesari M., Penninx B., Newman A., Kritchevsky S., Nicklas J., Sutton-Tyrrell K., et al. Inflammatory markers and cardiovascular disease (the health, aging and body composition [health ABC] study). Am J Cardiol 2003, 92:522-528.
16. Nishida H., Horio T., Suzuki Y., Iwashima Y., Tokudome T., Yoshihara F., et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine 2010, 34:78-98.
17. Daniels L., Maisel A. Natriuretic peptides. J Am Coll Cardiol 2007, 50.
18. Nagaya N., Nishikimi T., Okano Y., Uematsu M., Satoh T., Kyotani S., et al. Plasma brain natriuretic peptide levels increase in proportion to the extend of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998, 31:2002-2008.
19. Smith J., Goertze J., Andersen C., Vejlstrup N. Practical application of natriuretic peptides in paediatric cardiology. Cardiol Young 2010, 20:353-363.
20. Pascotto M., Santoro G., Cerrato F., Caputo S., Bigazzi M., Iacono C., et al. Time-course of cardiac remodelling following transcatheter closure of atrial septal defect. Int J Cardiol 2006, 112:348-352.
21. Eerola A., Jokinen E., Boldt T., Mattila I., Pihkala J. Serum levels of natriuretic peptides in children before and after treatment for an atrial septal defect, a patent ductus arteriosus, and a coarctation of the aorta- a prospective study. Int J Pediatr 2010.
22. Muta H., Ishii M., Maeno Y., akagi T., Kato H. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcaheter closure of atrial septal defect. Acta Paediatr 2002, 91:649-652.
23. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougashaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994, 90:195-203.
24. Sousa A.C. Left atrial volume as an index of diastolic function. Arquivos Brasileiros de Cardiologia 2006, 87:27-33.
25. Teo K.S.L., Dundon B.K., Molaee P., Williams K.F., Carbone A., Brown M.A., et al. Percutaneous closure of atrial septal deefcts leads to normalisation of atrial and ventricular volumes. J Cardiovas Magn Reson 2008, 10.
26. Lim T., Ashrafian H., Dwivedi G., Collinson P.O., Senior R. Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: implication for diagnosis of diastolic heart failure. Eur J Heart Fail 2006, 8:38-45.
27. Uz O., Aparci M., Acar G., Kardesoglou E., Kaplan O., Yiginer O., et al. Association of plasma B-type natriuretic peptide levels with shunt size in young adults with atrial septal defect. Echocardiography 2011.
28. Salehian O., Horlick E., McLaughlin P., Siu M., Webb G., Therrien J. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol 2005, 45:499-504.
29. Thilen U., Persson S. Closure of atrial defect in the adult. Cardiac remodelling is an early event. Int J Cardiol 2006, 108:370-375.
30. Ikonomides I., Andreotti E., Economou E., Stefanadis C., Toutouzas P., Nikoyannopoulos P. Increased proinflamatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999, 100:793-798.
31. Meune C., Wabbi K., Fulla Y., Cohen-Solal A., Duboc D., Mahe I., et al. Effects of asprin and clopidogrel on plasma brain natriuretic peptide in patients with heart failure receiving ACE inhibitors. Eur J Heart Fail 2007, 9:197-201.